加载中
NASDAQFinancial ServicesShell Companies
最新数据
US$12.50
+US$0.39 · +3.22%
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
前收盘价
US$12.50
+US$0.39 · +3.22%
盘后
US$12.18
−US$0.32 · -2.56%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
52周区间
当前US$12.50
盘中时间采用ET。市场数据可能有所延迟。
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
52周区间
当前US$12.50
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 销售、一般及管理费用 | 83.58万 USD | — | 2.85万 USD |
| 营业费用 | 83.58万 USD | 106.5万 USD | 2.85万 USD |
| 利息收入 | 189.55万 USD | 361.7万 USD | 19.98万 USD |
| 营业利润 | −83.58万 USD | −106.5万 USD | −2.85万 USD |
| 净利润 | 105.98万 USD | 255.2万 USD | 17.14万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
